United Therapeutics
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Maryland, United States · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
1000 Spring St, Silver Spring, Maryland,...Phone Number
(301) 608-9292Website
www.unither.comRevenue
$3.2 BillionStock Symbol
UTHRIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
2
2
2
1
1
1
About United Therapeutics
United Therapeutics Corporation is a biotechnology company focused on the discovery, development, manufacturing, and commercialization of innovative therapies and advanced medical technologies for patients living with chronic, rare, and life-threatening diseases. The company is dedicated to addressing significant unmet medical needs by developing novel pharmaceutical treatments that improve patient outcomes and enhance quality of lifeExplore more
United Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is United Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at United Therapeutics
Check out if United Therapeutics is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if United Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Click to see if United Therapeutics had a recent Job posting/layoffs
Product Launch: Get notified when United Therapeutics launches new products
Earning: See what the market has to say on United Therapeutics recently announced quarterly report
Funding: Get notified immidiatlly once United Therapeutics has new funding data
United Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to United Therapeutics
Compare insights from companies similar to United Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
United Therapeutics
$3.2B
1K - 5K
Public
$54M
1996
HH
Harsh HurkatSenior Analyst - Chief Financial Officer Org
$1.7B
1K - 5K
Private
$18M
1992
Sean GormanDirector, Business Planning & Operations Medical Office Chief & Chief Marketing Officer
Company Profile Activity
Activity Insights
United Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
United Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about United Therapeutics.
United Therapeutics financials insights
Gather financial insights about United Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
1999
Stock Offering
$54M
United Therapeutics Tech Stack
A closer look at the technologies used by United Therapeutics
Most Recent Scoops
Open Position
Open Position
Project
anticipates potential regulatory approvals in 2027 for nebulized Tyvaso in IPF, ralinepag in PAH, and the SMI device in PAH and PH-ILD, which the company views as multibillion-dollar catalysts with the potential to redefine patient treatment paradigms and transform its growth profile.
Product Development, Pharmaceuticals
Person-Based
Sales, Patient Experience, Revenue Operations
Person-Based
Pain Point, Earnings, Finance
United Therapeutics News & Media
Therapeutics Stocks Q2 Teardown: United Therapeutics (NASDAQ:UTHR) Vs The Rest
Wrapping up Q2 earnings, we look at the numbers and key takeaways for the therapeutics stocks, including United Therapeutics (NASDAQ:UTHR) and its peers.United Therapeutics Corporation (UTHR) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript
United Therapeutics Corporation (UTHR) Wells Fargo 21st Annual Healthcare Conference September 8, 2026 11:00 AM EDTCompany ParticipantsMartine Rothblatt -...Biotech Firm Buys Former Merrimack Anheuser-Busch Brewery for $47 million
Business NH Magazine was started in 1983 as New Hampshire's first statewide monthly business publication. Today, the magazine is known for its in-depth business coverage, special reports and directories, and competitions that celebrate the strength of the state's business community.United Therapeutics CEO Sells $5 Million of Shares. What Does This Mean for Investors?
Martine Rothblatt exercised options at $135.42 and sold at $530.42 under a pre-established Rule 10b5-1 plan, reducing her stake by just 1% while maintaining $353.1 million in equity value.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding United Therapeutics
Sign Up For FreeTo access detailed company insights
United Therapeutics Corporation is a biotechnology company focused on the discovery, development, manufacturing, and commercialization of innovative therapies and advanced medical technologies for patients living with chronic, rare, and life-threatening diseases. The company is dedicated to addressing significant unmet medical needs by developing n... Read More
